Triple Negative Breast Cancer and Celecoxib. Pilot Study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Triple Negative Breast Cancer and Celecoxib. Pilot Study — Stella

Home/Triple-Negative Breast Cancer/

View on ClinicalTrials.gov

Recruiting

Back to Triple-Negative Breast Cancer trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Canada

Faculty of medicine and health sciences, Sherbrooke, Quebec

Key details

Phase

Safety & dosing

Sponsor

Université de Sherbrooke

Enrollment target

~30 participants

Started

August 2025

Primary completion

August 2028

Age range

18 Years and older

Sex

Female only

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

Last updated August 2025